According to projections, the global placental growth factors market size is expected to rise significantly over the next ten years, rising from US$ 34.9 million in 2023 to over US$ 64.6 million in 2033, or a strong compound annual growth rate of 6.3%.
The Placental Growth Factors market revolves around therapeutic interventions and diagnostic procedures closely tied to the vital proteins known as placental growth factors. These proteins play a pivotal role in the growth and function of the placenta during pregnancy. They promote angiogenesis, the creation of new blood vessels, and regulate the proliferation and differentiation of placental cells, among other essential functions.
Get a Sample Copy of the Report:
https://www.futuremarketinsights.com/reports/sample/rep-gb-17629
Key Market Drivers:
- Rising Pregnancy-Related Disorders: The escalating prevalence of pregnancy-related disorders, such as preeclampsia, gestational diabetes, intrauterine growth restriction (IUGR), and placental insufficiency, underscores the need for effective diagnostic tools and therapeutic interventions.
- Enhancing Prenatal Care: Early detection and risk assessment are gaining paramount importance in prenatal care. Placental growth factors like placental growth factor (PlGF) and soluble fms-like tyrosine kinase-1 (sFlt-1) serve as critical biomarkers in assessing the likelihood of pregnancy complications.
- Heightened Awareness: Increasing awareness among healthcare professionals, patients, and advocacy groups regarding the pivotal role of placental health in influencing pregnancy outcomes is propelling the demand for placental growth factors.
As the demand for effective interventions and diagnostics related to placental growth factors continues to rise, the market is at the forefront of advancing maternal and fetal health. Placental growth factors have emerged as indispensable tools in ensuring the well-being of both mother and child during pregnancy.
The future of maternal healthcare is poised for transformation, with Placental Growth Factors playing a vital role in enhancing the health and outcomes of pregnancies worldwide.
Unlock Tailored Insights: Customize Your Report for Maximum Impact:
https://www.futuremarketinsights.com/customization-available/rep-gb-17629
Key Players:
- Alteogen Inc.
- Chengdu Kanghong Pharmaceuticals Group Co Ltd
- Clearside BioMedical, Inc.
- Formycon AG
- Regeneron Pharmaceuticals Inc
- ThromboGenics NV
- Luye Pharma Group Ltd
- Alvotech SA
- Amgen Inc
- Celltrion Inc
- Cinnagen Co
- GlycoNex Inc
Key Developments :
In March 2023, The suprachoroidal space (SCS®) is being revolutionised by Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical firm. Its results for the fourth quarter and year ending December 31, 2022, were released along with a corporate update.
Segmentation Analysis of the Placental Growth Factors Market
By Therapy Areas:
- Ophthalmology
- Metabolic Disorder
- Oncology
- Others
By End User:
- Pharmaceutical and Biotechnology Companies
- Research Centers & Academic Institutes
- CMO and CDMO
By Region:
- North America
- Latin America
- Europe
- East Asia
- South Asia
- Oceania
- The Middle East & Africa
Unlock exclusive insights with our expert analysts :
https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-17629
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
